Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02377440 · ClinicalTrials.gov registry record
Effects of ACEI on Bone Turnover
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 32
- Enrollment target
NCT02377440: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT02377440 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02377440 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The investigators hypothesize that older persons (≥45 years) treated with ACEI for HTN control will have: i) improved status of bone turnover (decreased P1NP and CTX), and ii) decreased levels of RANKL and RANKL/OPG, compared to those not treated with ACEI and not using RAS-related medications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-12 |
What the finished NCT02377440 record still lists
NCT02377440 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02377440 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02377440 about?
NCT02377440 is a clinical study titled "Effects of ACEI on Bone Turnover". The investigators hypothesize that older persons (≥45 years) treated with ACEI for HTN control will have: i) improved status of bone turnover (decreased P1NP and CTX), and ii) decreased levels of RANKL and RANKL/OPG, compared to those not treated with ACEI and not using RAS-related medications
What is the current status of trial NCT02377440?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2013-10. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT02377440?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia